Perturbations in neuronal protein homeostasis likely contribute to disease pathogenesis in polyglutamine (polyQ) neurodegenerative disorders. Here we provide evidence that the co-chaperone and ubiquitin ligase, CHIP (C-terminus of Hsp70-interacting protein), is a central component to the homeostatic mechanisms countering toxic polyQ proteins in the brain. Genetic reduction or elimination of CHIP accelerates disease in transgenic mice expressing polyQ-expanded ataxin-3, the disease protein in Spinocerebellar Ataxia Type 3 (SCA3). In parallel, CHIP reduction markedly increases the level of ataxin-3 microaggregates, which partition in the soluble fraction of brain lysates yet are resistant to dissociation with denaturing detergent, and which precede the appearance of inclusions. The level of microaggregates in the CNS, but not of ataxin-3 monomer, correlates with disease severity. Additional cell-based studies suggest that either of two quality control ubiquitin ligases, CHIP or E4B, can reduce steady state levels of expanded, but not wild-type, ataxin-3. Our results support an aggregation model of polyQ disease pathogenesis in which ataxin-3 microaggregates are a neurotoxic species, and suggest that enhancing CHIP activity is a possible route to therapy for SCA3 and other polyQ diseases.
Introduction
The crowded intracellular environment presents obstacles to proper folding of proteins. Accordingly, cells contain a molecular chaperone network that facilitates protein folding and promotes degradation of misfolded proteins. Its importance in the nervous system is highlighted by various neurodegenerative disorders, in which protein conformational defects cause detrimental accumulation of misfolded or aggregated protein. Protein misfolding and aggregation may underlie neurodegeneration in diseases such as Parkinson's disease, Alzheimer's disease and the polyglutamine (polyQ) diseases (Taylor et al., 2002; Selkoe, 2004; Walsh and Selkoe, 2004) . Although protein aggregation occurs in all of these diseases, how protein misfolding and aggregation damages neurons is unclear. In the polyQ diseases, moreover, it is unknown which protein species are neurotoxic: monomers, oligomers, or higher order aggregates.
Aggregation is a common byproduct of protein misfolding, suggesting that protein quality control (PQC) systems are important in countering diseases where aggregation occurs. Two PQC pathways implicated in disease are the molecular chaperone system and the ubiquitin-proteasome pathway (Bence et al., 2001; Hay et al., 2004; Marques et al., 2006) . The cochaperone and ubiquitin ligase, CHIP, links these two systems. Through its N-terminus, CHIP binds heat shock proteins and modulates protein refolding (Ballinger et al., 1999; Connell et al., 2001) . Through its C-terminus, CHIP ubiquitinates substrates and targets them for degradation (Connell et al., 2001; Meacham et al., 2001) .
The dual roles of CHIP in chaperone-and ubiquitin-dependent pathways suggest that it might be important in neuronal PQC. Numerous studies support a role for CHIP in countering neurodegenerative diseases. For example, CHIP enhances the activity of parkin, a protein associated with recessive parkinsonism (Imai et al., 2002) , and regulates the degradation of phosphorylated tau, a protein implicated in various neurodegenerative diseases (Dickey et al., 2006 (Dickey et al., , 2007a . Although CHIP modulates the toxicity of several polyQ disease proteins (Jana et al., 2005; Miller et al., 2005; Al-Ramahi et al., 2006; Choi et al., 2007; Branco et al. 2008 ), the precise role of CHIP in polyQ diseases is difficult to delineate because it may regulate polyQ proteins differently depending on protein context (Al-Ramahi et al., 2006; Bulone et al., 2006; Dickey et al., 2007b; Branco et al. 2008) .
Expansion of the polyQ domain in the ataxin-3 protein causes the polyQ disease, SCA3. While normal ataxin-3 can self-associate (Gales et al., 2005) , polyQ expansion enhances its aggregation and promotes Neurobiology of Disease 33 (2009) 342-353 
